Bolenol
Bolenol (INN, USAN), also known as 17α-ethyl-19-norandrost-5-en-17β-ol (ethylnorandrostenol), is a synthetic, orally active anabolic-androgenic steroid (AAS) and a 17α-alkylated derivative of 19-nortestosterone (nandrolone) that was never marketed.[1] It was described in the literature in 1969.[1]
 | |
| Clinical data | |
|---|---|
| Other names | Ethylnorandrostenol; 17α-Ethyl-19-norandrost-5-en-17β-ol |
| Routes of administration | By mouth |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| ECHA InfoCard | 100.037.226  |
| Chemical and physical data | |
| Formula | C20H32O |
| Molar mass | 288.475 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
See also
References
- Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 168–. ISBN 978-1-4757-2085-3.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.